Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

 

Oral Abstract CML-044: Treatment-Free Remission (TFR) in Patients with Chronic-Phase Chronic Myeloid Leukemia (CML-CP) and Stable Deep Molecular Response (DMR) Discontinuing Dasatinib

November 5, 2018

0 Comments
Login to view comments. Click here to Login
Leukemia